Beta-arrestins and Response to Venlafaxine in Major Depressive Disorder (MDD) (DEPARRESTCLIN)

NCT02051413 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

67

Enrollment

OTHER_GOV

Sponsor class

Conditions

Major Depressive Disorder
Major Depressive Episode

Interventions

DRUG: Venlafaxine extended release

Sponsor

Institut National de la Santé Et de la Recherche Médicale, France